• Molecular NameMupirocin
  • SynonymMRC; mupirocin; Mupirocine; Pseudomonic acid
  • Weight500.629
  • Drugbank_IDDB00410
  • ACS_NO12650-69-0
  • Show 3D model
  • LogP (experiment)2.611
  • LogP (predicted, AB/LogP v2.0)3.0
  • pka5
  • LogD (pH=7, predicted)0.9
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.79
  • LogSw (predicted, AB/LogsW2.0)0.06
  • Sw (mg/ml) (predicted, ACD/Labs)0.07
  • No.of HBond Donors4
  • No.of HBond Acceptors9
  • No.of Rotatable Bonds17
  • TPSA155.28
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antibiotic originally isolated from Pseudomonas fluorescens NCIMB 10586
  • Absorption_valueN/A
  • Absorption (description)No measurable systemic absorption
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding96.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half lifeAfter IV administration, mupirocin, 15 to 30 min; monic acid, 32 to 78 min.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A